Abstract
IL-22 is a Th17 T-cell-associated cytokine that is highly expressed during chronic inflammation. IL-22 receptor expression is absent on immune cells, but is instead restricted to the tissues, providing signaling directionality from the immune system to the tissues. Through Stat3 signaling, IL-22 induces a variety of proliferative, anti-apoptotic, and anti-microbial pathways. IL-22 is bi-functional with both pro-inflammatory and protective effects on tissues depending on the inflammatory context. The cytokine plays a role both in the host response against extracellular pathogens and in the inflammation associated with autoimmune diseases. Therapeutics targeting IL-22 therefore may have promise for treating various chronic inflammatory diseases. © 2008 Wiley-VCH Verlag GmbH & Co. KGaA.
Author supplied keywords
Cite
CITATION STYLE
Zenewicz, L. A., & Flavell, R. A. (2008). IL-22 and inflammation: Leukin’ through a glass onion. European Journal of Immunology. https://doi.org/10.1002/eji.200838655
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.